634 related articles for article (PubMed ID: 8557506)
1. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
[TBL] [Abstract][Full Text] [Related]
2. [A pharmacokinetic analysis of Gd-DTPA enhancement in MRT in breast carcinoma].
Hess T; Knopp MV; Hoffmann U; Brix G; Junkermann H; Zuna I; von Fournier D; van Kaick G
Rofo; 1994 Jun; 160(6):518-23. PubMed ID: 8011997
[TBL] [Abstract][Full Text] [Related]
3. Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours.
Mussurakis S; Buckley DL; Drew PJ; Fox JN; Carleton PJ; Turnbull LW; Horsman A
Clin Radiol; 1997 Jul; 52(7):516-26. PubMed ID: 9240704
[TBL] [Abstract][Full Text] [Related]
4. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.
Stomper PC; Herman S; Klippenstein DL; Winston JS; Edge SB; Arredondo MA; Mazurchuk RV; Blumenson LE
Radiology; 1995 Nov; 197(2):387-95. PubMed ID: 7480682
[TBL] [Abstract][Full Text] [Related]
5. Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography.
Gribbestad IS; Nilsen G; Fjøsne HE; Kvinnsland S; Haugen OA; Rinck PA
J Magn Reson Imaging; 1994; 4(3):477-80. PubMed ID: 8061451
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging in potential postsurgical recurrence of breast cancer: pitfalls and limitations.
Cohen EK; Leonhardt CM; Shumak RS; Soutar IC; Bukhanov K; Fishell EK; Plewes DB
Can Assoc Radiol J; 1996 Jun; 47(3):171-6. PubMed ID: 8640412
[TBL] [Abstract][Full Text] [Related]
7. Dynamic 3D-MR mammography: is there a benefit of sophisticated evaluation of enhancement curves for clinical routine?
Müller-Schimpfle M; Ohmenhäuser K; Sand J; Stoll P; Claussen CD
J Magn Reson Imaging; 1997; 7(1):236-40. PubMed ID: 9039622
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three-dimensional MRI of breast lesions.
den Boer JA; Hoenderop RK; Smink J; Dornseiffen G; Koch PW; Mulder JH; Slump CH; Volker ED; de Vos RA
J Magn Reson Imaging; 1997; 7(4):702-15. PubMed ID: 9243392
[TBL] [Abstract][Full Text] [Related]
9. Clustered breast microcalcifications: evaluation by dynamic contrast-enhanced subtraction MRI.
Gilles R; Meunier M; Lucidarme O; Zafrani B; Guinebretière JM; Tardivon AA; Le Gal M; Vanel D; Neuenschwander S; Arriagada R
J Comput Assist Tomogr; 1996; 20(1):9-14. PubMed ID: 8576489
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced magnetic resonance imaging of the breast.
Heywang-Köbrunner SH
Invest Radiol; 1994 Jan; 29(1):94-104. PubMed ID: 8144345
[No Abstract] [Full Text] [Related]
11. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G
AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955
[TBL] [Abstract][Full Text] [Related]
12. Dynamic MRI of invasive breast cancer: assessment of three region-of-interest analysis methods.
Mussurakis S; Buckley DL; Horsman A
J Comput Assist Tomogr; 1997; 21(3):431-8. PubMed ID: 9135653
[TBL] [Abstract][Full Text] [Related]
13. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer.
Fischer U; Zachariae O; Baum F; von Heyden D; Funke M; Liersch T
Eur Radiol; 2004 Oct; 14(10):1725-31. PubMed ID: 15248080
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced and fat suppressed magnetic resonance imaging in suspected recurrent carcinoma of the breast: preliminary experience.
Kerslake RW; Fox JN; Carleton PJ; Imrie MJ; Cook AM; Bowsley SJ; Horsman A
Br J Radiol; 1994 Dec; 67(804):1158-68. PubMed ID: 7874413
[TBL] [Abstract][Full Text] [Related]
16. Kinetic characteristics of ductal carcinoma in situ (DCIS) in dynamic breast MRI using computer-assisted analysis.
Vag T; Baltzer PA; Dietzel M; Benndorf M; Gajda M; Camara O; Kaiser WA
Acta Radiol; 2010 Nov; 51(9):955-61. PubMed ID: 20942728
[TBL] [Abstract][Full Text] [Related]
17. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
18. Dynamic magnetic resonance mammography of both breasts following local excision and radiotherapy for breast carcinoma.
Murray AD; Redpath TW; Needham G; Gilbert FJ; Brookes JA; Eremin O
Br J Radiol; 1996 Jul; 69(823):594-600. PubMed ID: 8696694
[TBL] [Abstract][Full Text] [Related]
19. MR imaging of the breast after surgery for breast cancer.
Whitehouse GH; Moore NR
Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):591-603. PubMed ID: 7489311
[TBL] [Abstract][Full Text] [Related]
20. [Gadolinium-DTPA (Magnevist) as contrast medium for galactography].
Kaltenborn H; Schadmand S; Beck T; Thelen M
Rofo; 1995 Nov; 163(5):457-9. PubMed ID: 8527765
[No Abstract] [Full Text] [Related]
[Next] [New Search]
